Dexcom Inc., US2521311074

Dexcom Inc. stock pre-market at EUR 77.60: plus 0.52 percent

Published on 10/06/2026 at 08:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Dexcom stock was at EUR 77.60 pre-market at 8:47 a.m. CEST on October 6, 2026, up 0.52 percent versus the prior close at Lang & Schwarz. The company also highlighted a new diabetes-care report and partnership.

Fotorealistischer CGM-Sensor-Patch am Arm, klinisches Umfeld, Medizintechnik
Dexcom Inc. zeigt fotorealistischen CGM-Sensor am Unterarm für Anleger mit ISIN US2521311074 Medizintechnik, Illustration mit AI erstellt.

Dexcom Inc. stock was at EUR 77.60 pre-market at 8:47 a.m. CEST on October 6, 2026, according to Lang & Schwarz. That was plus 0.52 percent versus the EUR 77.20 prior close at Lang & Schwarz on October 5, 2026.

Dexcom before the Xetra open

Lang & Schwarz listed a bid of EUR 77.20 and an ask of EUR 78.00. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Dexcom Inc. stock.

Prior close at Lang & Schwarz

The prior close at Lang & Schwarz was EUR 77.20 on October 5, 2026. The current pre-market indication and that prior close are both euro prices from Lang & Schwarz and are stated separately from the company news.

Report and Team Novo Nordisk partnership

In a September 28, 2026, release, Dexcom said it had released its 2026 State of Type 2 Report during the European Association for the Study of Diabetes meeting in Milan. The company said the report surveyed more than 800 healthcare professionals and 2,500 people with Type 2 diabetes across eight countries.

The release also said Dexcom had announced a partnership with Team Novo Nordisk to become the team’s official continuous glucose monitoring partner. Dexcom described the partnership as creating opportunities for real-world research, education and awareness related to glucose insights.

Disclaimer...

en | US2521311074 | DEXCOM INC. | boerse | 70239650 | bgmi